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Gating defects of disease-causing de novo mutations in Cav1.3 Ca
2+ channels
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and Jörg Striessnig a
aDepartment of Pharmacology and Toxicology, Institute of Pharmacy and Center for Molecular Biosciences, University of Innsbruck,
Innsbruck, Austria; bWilliam Harvey Research Institute, Queen Mary University of London, London, UK
ABSTRACT
Recently, we and others identified somatic and germline de novo gain-of-function mutations in
CACNA1D, the gene encoding the α1-subunit of voltage-gated Cav1.3 Ca
2+-channels. While
somatic mutations identified in aldosterone producing adenomas (APAs) underlie treatment-
resistant hypertension, germline CACNA1D mutations are associated with a neurodevelopmental
disorder characterized by a wide symptomatic spectrum, including autism spectrum disorder. The
number of newly identified CACNA1D missense mutations is constantly growing, but their patho-
genic potential is difficult to predict in silico, making functional studies indispensable to assess
their contribution to disease risk.
Here we report the functional characterization of previously identified CACNA1D APA muta-
tions F747L and M1354I using whole-cell patch-clamp electrophysiology upon recombinant
expression in tsA-201 cells. We also investigated if alternative splicing of Cav1.3 affects the
aberrant gating of the previously characterized APA mutation R990H and two mutations asso-
ciated with autism spectrum disorder (A479G and G407R). Splice-variant dependent gating
changes are of particular interest for germline mutations, since the relative expression of Cav1.3
splice variants differs across different tissues and within brain regions and might therefore result
in tissue-specific phenotypes. Our data revealed a complex gain-of-function phenotype for APA
mutation F747L confirming its pathogenic role. Furthermore, we found splice-variant dependent
gating changes in R990H, A749G and G407R. M1354I did not change channel function of Cav1.3
splice variants and should therefore be considered a rare non-pathogenic variant until further
proof for its pathogenicity is obtained. Our new findings together with previously published data
allow classification of pathogenic CACNA1D mutations into four categories based on prototypical
functional changes.
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Introduction
Different classes of voltage-gated Ca2+ channels
serve a central role for key physiological processes
by generating inward Ca2+ currents in response to
changes in membrane potentials in electrically
excitable cells [1–3]. Ca2+ influx through these
channels drives not only membrane depolarization
but, through Ca2+ ions as universal second mes-
senger, also regulates a large variety of intracellular
Ca2+ dependent processes. These include muscle
contraction, gene transcription, hormone secre-
tion, neurotransmitter release, synaptic excitability
and plasticity [1–3]. Their subcellular targeting as
well as the dynamics of Ca2+ entry need to be
tightly controlled by accessory subunits, post-
translational modification, lipid- and protein
interactions, as well as alternative splicing [1,2].
The occurrence of human channelopathies result-
ing from even minor changes in Ca2+ channel
activity [4–8] further emphasizes the importance
of strictly regulated channel gating and targeting
for normal physiological function.
We [9–12] and others [13–16] have recently
described de novo missense mutations in
CACNA1D encoding the pore-forming α1-subunit
of Cav1.3 L-type channels. These included somatic
mutations identified in aldosterone-producing ade-
nomas [APAs, 11,12,15], as well as germline muta-
tions from patients with neurodevelopmental
disorders characterized by autism spectrum disorder
(ASD) and/or intellectual disability with or without
seizures [9,10,13–15]. Three of these patients further
displayed primary aldosteronism or hyperinsulinism
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[13,15]. All so far functionally characterized muta-
tions – both from germline and somatic mutations –
induced pronounced gating changes, evident either
as robust shifts in activation and inactivation voltage
to more negative potentials and/or strong reductions
of ICa inactivation, thus permitting enhanced Ca
2+
entry through the channel. This suggests that Cav1.3
gain-of-function cannot only drive excessive aldos-
terone production in APAs [Ca2+ is the critical
steroidogenic secondmessenger in zona glomerulosa
cells, 17] but might also confer high risk for neurop-
sychiatric and neurological disorders [18].
Due to the known physiological role of Cav1.3
for brain development and function [2,18] and the
recent findings of recurrent de novo germline
CACNA1D mutations in patients with neuropsy-
chiatric and neurological symptoms this gene has
been incorporated in custom genetic panels for
clinical diagnosis, including autism/intellectual
disability (Autism/ID Xpanded Panel).
Based on findings in Cav1.3-deficient mice [19]
and humans [20] heterozygous de novo loss-of-
function mutations are expected to be clinically
silent and only missense mutations with gating
changes permitting enhanced Ca2+ signaling are
likely to be disease relevant. However, the functional
consequences of such mutations are difficult to pre-
dict in silico. Therefore, newly identified rare mis-
sense variants have to be functionally characterized
in heterologous expression systems to confirm their
disease causing potential. So far this has been accom-
plished for seven patients with germline CACNA1D
mutations [six different mutations, 9,10,13–15] and
six somatic mutations occurring in APAs
[11,12,15,21]. Interestingly, several of the function-
ally verified germline mutations causing
a neurodevelopmental disorder are also found in
APAs [I750M, G403D, V401L, 18]. Therefore, if
a germline mutation in patients with
a neurodevelopmental syndrome is also reported in
APAs this would be strong support for its pathogenic
role and guide genetic and clinical diagnosis. The
number of CACNA1D mutations in APAs in pre-
cursor lesions (aldosterone producing cell clusters,
APCCs,) is constantly growing [>40, 18,22,23]. All
these mutations are highly likely to allow enhanced
Ca2+ signaling though Cav1.3 channels because they
are selected by their ability to drive Ca2+ -dependent
aldosterone production. However, despite this
selection pressure not all predicted high confidence
CACNA1DAPA and APCCmutations may strongly
contribute to disease risk because other, yet
unknown mechanisms could be responsible.
Notably, a substantial fraction of excessive aldoster-
one production in APAs is due to mechanisms not
explained by somatic variants in known genes [24].
This emphasizes the need for further functional
characterization of CACNA1D APA mutations to
verify their causative roles.
Here we report the analysis of three APA muta-
tions (F747L, R990H, M1354I) which we have
previously reported together with other
CACNA1D mutations in a cohort of 152 subjects
[11]. We also investigated if alternative splicing of
Cav1.3 α1 can affect mutational effects on channel
function in R990H, M1354I and in two previously
reported ASD mutations A749G and G407R.
Indeed, we found splice-variant dependent gating
changes in R990H, A749G and G407R. Our data
confirm a gain-of function phenotype also for
F747L but not for M1354I. Finally, our experi-
ments support our previous hypothesis that an ω-
current through mutant R990H rather than altered
gating explains its pathogenic potential.
Experimental procedures
Complementary DNA constructs
Human wild-type Cav1.3α1-subunits (reference
sequence EU363339) comprising alternative exons
8a and 42 (long C-terminal splice variant) or 43s
[short C-terminal splice variant, 25] were previously
cloned into the pGFPminus vector (no GFP tag, CMV
promoter) [25]. Mutations were introduced into Cav
1.3 splice variants using standard polymerase chain
reaction approaches and verified by Sanger sequen-
cing (Eurofins Genomics, Ebersberg, Germany).
When co-expressed with auxiliary β3 and α2δ-1 sub-
units in tsA-201 cells, all mutant α1-subunits were
detected with the expected molecular mass in
Western blots and at densities comparable to wild-
type (n ≥ 3 transfections for each mutant).
Cell culture and transfection
tsA-201 cells were maintained in culture and tran-
siently transfected with wild-type (WT) or mutant
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Cav1.3 α1- and auxiliary β3- (NM_012828) and α2
δ-1- (NM_001082276) subunits as previously
described [9,26]. GFP was co-transfected to visua-
lize transfected cells.
Electrophysiological recordings in tsA-201 cells
For whole-cell patch-clamp recordings borosilicate
glass electrodes (203-776-0664 Warner
Instruments and 64-0792, Harvard Apparatus,
USA) with a final resistance of 1.5–3.0 MΩ were
pulled using a micropipette puller (Sutter instru-
ments, P-97) and fire polished afterwards
(Microforge, Narishinge MF-830). All recordings
were performed at room temperature (21–23 °C)
in whole-cell configuration using the Axopatch
200B amplifier (Axon instruments), digitized at
50 kHz (Digitizer 1322A, Axon instruments), low-
pass filtered at 5 kHz and compensated for 60–90
% of the series resistance. The recording solutions
contained in mM: bath: 15 CaCl2, 10 HEPES, 150
choline-Cl and 1 MgCl2, adjusted to pH 7.4 with
CsOH; intracellular: 135 CsCl, 10 HEPES, 10 Cs-
EGTA, 1 MgCl2, 4 Na2ATP adjusted to pH 7.4
with CsOH. The holding potential (HP) was set
to −80 mV. To determine the current-voltage
(I-V) relationship, a 30 ms (short splice variants)
or 50 ms (long splice variants) square pulse pro-
tocol to different voltages was applied. Resulting
I-V curves were fitted from −80 mV to + 40 mV to
the following equation:
I ¼Gmax VVrevð Þ= 1þ exp  V V0:5ð Þ=kð Þð Þ
where Vrev is the extrapolated reversal potential,
V the test potential, I the peak current, Gmax the
maximum conductance, V0.5 the half maximal
activation voltage and k the slope factor. The vol-
tage-dependence of Ca2+ conductance was fitted
according to a Boltzman distribution:
G ¼Gmax= 1þ exp  VV0:5ð Þ=kð Þð Þ:
Estimates for changes in channel open probability
and/or single channel conductance were obtained
as described [25] by normalizing the ionic tail
current to the amplitude of the integrated ON-
gating current (QON) of the same pulse at the
Vrev. The QON at the Vrev was also used to deter-
mine the surface expression of the channel
complexes.
For analysis of current densities, surface expres-
sion and estimation of the open probability only
recordings from the same transfections were
compared.
Steady-state inactivation was measured by
applying a control test pulse (20 ms to the voltage
of maximal inward current, Vmax) followed by
5-s conditioning steps to various potentials and
a subsequent 20-ms test pulse to Vmax (30-s recov-
ery between protocols). Inactivation was calculated
as the ratio between the current amplitudes of the
test versus control pulse. Steady-state inactivation
parameters were obtained by fitting the data to
a modified Boltzmann equation:
G ¼ 1Gmaxð Þ= 1þ exp VV0:5ð Þ=kð Þð ÞþGmax:
To investigate inactivation kinetics, cells were
depolarized for 5 s to the Vmax, normalized
(I/Imax) and the remaining current (R) at different
time points was determined. Recovery from inac-
tivation was determined by a 10 ms test pulses to
Vmax at the indicated time after a 1-s conditioning
pulse to Vmax. Differences in the inactivation after
repeated stimuli were determined after applying
100-ms square pulses to Vmax at a frequency of
3 Hz. Holding potential between the steps was
−60 mV.
Leak subtraction was performed either offline
(steady-state inactivation, 5-s inactivation, recov-
ery from inactivation and pharmacological experi-
ments) or online using P/4 protocol. Recordings
were junction potential corrected by −9.3 mV for
Ca2+ and by −8.6 for Ba2+ as charge carrier, as
previously described [27].
Statistics
Data were analyzed using Clampfit 10.2 (Axon
Instruments), Microsoft Excel, SigmaPlot 8
(Systat Software, Inc) and GraphPad Prism 5 soft-
ware (GraphPad software, Inc). All values are pre-
sented as mean ± S.E.M. for the indicated number
of experiments (n) unless stated otherwise. Data
were analyzed by unpaired Student’s t-test, Mann-
Whitney test, and one-way ANOVA followed by
Bonferroni post-hoc test. Statistical significance
was set at p < 0.05.
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Results
Splice-variant dependent effects of ASD
mutations G407R and A749G
We have recently shown that two de novo missense
mutations, G407R and A749G (Figure 1), found in
two patients with ASD cause severe gating changes
that are expected to result in aberrant Cav
1.3-mediated Ca2+ signaling in the brain. Together
with three other mutations (V401L, G407D, I750M)
that cause an even more severe neurodevelopmental
syndrome [9,15], this strongly suggests that these
mutations confer a high risk for these diseases [18].
Cav1.3 also undergoes extensive alternative splicing,
giving rise to a major C-terminal long splice variant
(Cav1.3L) and a number of C-terminal short splice
variants, with Cav1.343s (Cav1.3S) being the most
abundant one in the brain [25,28–30]. C-terminal
splicing removes a modulatory domain allowing
channels to undergo major changes in voltage-and
Ca2+-dependent gating resulting in activation at
lower voltages, enhanced Ca2+-dependent inactiva-
tion and increased channel open probability
[25,27,28,31]. We have previously reported gating
effects of the germline mutations A749G and
G407R (situated at the intracellular end of IS6 and
IIS6, respectively) only in the human C-terminally
long (Cav1.3L) isoform [10]. To test for potential
splice-variant dependent effects we now introduced
bothmutations into human Cav1.3S to compare their
functional consequences with those in Cav1.3L under
identical experimental conditions.
Mutation A749GS resulted in a similarly strong
negative shift of the voltage dependence of activa-
tion and steady-state inactivation as the long splice
variant (Figure 2(a,b), Table 1; historical data for
long splice variants measured under identical con-
ditions are given for comparison). Since wild-type
Cav1.3S activates and inactivates at more negative
voltages than Cav1.3L [Figure 2(a,b), Table 1, 26],
a substantial fraction of A749GS inactivated
already at negative voltages unable to activate
channels (closed-state inactivation), as evident
from the steady-state activation and inactivation
curves (Figure 2(b)). At −50 mV, where channels
were not activated, only 1.13 ± 0.01 % and
2.51 ± 0.01 % of WTL and WTS channels are
inactivated, whereas for A749GL 19.2 ± 0.03 %
and for A749GS even 41.8 ± 0.07 % were already
unavailable (p < 0.0001 for A749GL vs. WTL,
A749GS vs. WTS and A749GL vs. A749GS, one-
way ANOVA followed by Bonferroni post hoc
Figure 1. Transmembrane topology of the Cav1.3 α1-subunit. The pore-forming subunit of voltage gated Ca
2+ channels consist of
four transmembrane repeats each comprising six membrane spanning helices connected by intra- and extracellular linkers.
Segments (S) 1–4 of each repeat comprise the voltage- sensing domain, whereas segments 5–6 line the pore. The positions of
missense mutations identified in ASD (G407R, A749G) and APAs (F747L, R990H, M1354I) are indicated. Mutations G407R (IS6), F747L
(IIS6) and A749G (IIS6) reside within the so-called activation gate at the distal part of the S6 segment. Mutation R990H affects the
third of the five gating charges within the IIIS4 helix of the voltage sensing domain and M1354I is localized at the distal part of
segment IVS5 facing the extracellular side. For references see text.
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test). Since our measurements require recordings
with 15 mM Ca2+ as a charge carrier, voltage-
dependent activation and inactivation curves
would be shifted by about −18 mV at physiological
Ca2+ concentrations [2 mM Ca2+; 25]. Therefore,
about half of the A749GS channels are predicted to
Figure 2. Biophysical properties of Cav1.3 mutant A749GS. (a) Current-voltage relationships (ICa, mean ± S.E.M.; 50-ms depolariza-
tions to indicated voltages) of WTS and A749GS. Only WT data recorded in parallel on the same days (> 3- different transfections)
were included. Inset (upper): Box plots of WTS and A749GS peak current densities. In contrast to the long splice variant, no significant
difference was observed in the current amplitudes (median, 5/95 percentile, [pA/pF]): WTS: −8.74 (−22.4/-5.54) n = 10; A749GS: −6.18
(−26.4/-4.94), n = 12; p = 0.339, Mann Whitney test). Inset (lower): Representative ICa traces from WTS and A749GS during
depolarizations to Vmax. (b) Steady-state activation (circles, solid lines) and inactivation (squares, dashed lines) of WTS (black
symbols) and A749GS (orange symbols). For statistics and n-numbers see Table 1. Lines without symbols represent the correspond-
ing voltage-dependence of activation and inactivation for full length WTL and A749GL recorded under identical conditions (taken
from reference 10). (c) Inactivation time course of WTS (n = 35) and A749GS (n = 9) during depolarization to Vmax for 5 s. Normalized
traces are shown as mean ± S.E.M. Inactivation was best described by a bi-exponential decay. The faster inactivation of the mutant
resulted from a slightly larger contribution of the fast inactivating component (WTS: 79.1 ± 1.11 %, n = 26, A749GS: 84.3 ± 2.21 %,
p = 0.036, n = 8) and faster inactivation of the slow component (WTS: τslow = 602 ± 21.8 ms, A749GS: 420 ± 59.6 ms, p = 0.0012),
despite a moderately slower fast inactivation (WTS: τfast = 36.5 ± 1.8 ms, A749GS: 57.9 ± 7.99 ms, p = 0.0004). Additionally,
inactivation was more complete in the mutant (remaining current: WTS: 14.6 ± 2.5 %, A749GS: 5.65 ± 1.19 %, p = 0.061, for statistics
see Table 2). Statistical significance has been determined by unpaired Student’s t-test.
Table 1. Activation and inactivation parameters for ASD mutations A749G and G407R.
activation inactivation
Vrev [mV] Slope [mV] V0.5 [mV] n V0.5 [mV] Slope [mV] Remaining current [%] n
WTS 64.9 ± 1.04 7.71 ± 0.11 −9.49 ± 0.42 66 −31.7 ± 0.88 4.31 ± 0.12 11.5 ± 2.18 25
AGS 54.7 ± 1.46*** 6.61 ± 0.11*** −18.3 ± 1.34*** 13 −48.6 ± 1.58*** 4.27 ± 0.16 6.01 ± 1.50 9
GRS 61.6 ± 1.77 7.68 ± 0.28 −15.3 ± 2.20*** 14 nd
WTL 67.7 ± 1.14 8.92 ± 0.20 −2.55 ± 1.05 29 25.7 ± 2.08 5.56 ± 0.23 14.4 ± 3.12 18
AGL 60.3 ± 0.83
### 7.14 ± 0.20### −12.3 ± 0.87### 27 −41.1 ± 1.07### 5.82 ± 0.18 9.43 ± 1.49 14
GRL 54.7 ± 2.32
### 7.90 ± 0.30 −6.58 ± 1.41 13 nd
All values are presented as mean ± S.E.M. Number of independent transfections >3. Parameters were obtained after fitting normalized (I/Imax)
I-V relationships or normalized (I/Imax) steady-state inactivation curves, as described in Methods. Statistical analysis was performed using one-way
ANOVA and Bonferroni post-hoc test (activation) or unpaired Student’s t-test (steady-state inactivation). Significance **, ## p < 0.01, ***, ###
p < 0.001 in comparison to WTS (*) or WTL (
#) (statistical analysis has been performed separately for long and short splice variants). n, number of
experiments; nd, not determined; V0.5, half maximal activation/inactivation voltage; Vrev, reversal potential; WT, wild-type. Note small differences
among WT recordings within different sets of experiments (Tables 1, 3 and 5) because WT control experiments were always carried out in parallel
with mutated channels. Reference data, which were already published previously, are indicated in italics (taken from reference 10).
392 A. PINGGERA ET AL.
be already inactivated at membrane potentials
close to resting potentials. In the heterozygous
individuals this would decrease the availability of
A749Gs in comparison to wild-type channels in
neurons with more positive membrane potentials,
such as for example substantia nigra and ventral
tegmental area dopamine neurons. This reveals
both, gain- and loss of function properties of
these mutations depending not only on the activity
patterns of different neurons but also strongly
affected by the relative abundance of long and
short splice variants.
Mutation A749G slightly accelerated inactivation
kinetics of both splice variants (Table 2). Bi-
exponential inactivation over a 5-s time course of
A749GS was faster (Figure 2), due to a significant
decrease of τslow and an increase of the contribution
of the fast inactivating component (Figure 2(c), see
legend for statistics). τfast was slightly prolonged,
which was also evident from a trend to more
remaining current after 50 ms (Table 2). Although
we made no attempts to separate the contribution
of CDI and VDI for inactivation, the decrease of
τslow must reflect a slowing of VDI by the mutation,
whereas the increase in τfast suggests a slowing of
CDI. This agrees with the observation of reduced
CDI and enhanced VDI of this mutation in a rat
Cav1.3 splice variant [16]. The authors predicted
that the increase in VDI by the mutation may act in
opposition to the reduced of CDI. Our data provide
direct experimental support for their prediction.
As described previously [12,25] ON-gating cur-
rents (QON) were very small or absent for WTS
preventing measurements of the ratio of maximal
tail current amplitude vs. integrated ON-gating cur-
rent as an estimate for changes in open probability.
Whereas A749GL significantly enhanced peak cur-
rent amplitudes [10] this was not observed for
A749GS. Instead, depolarization to voltages causing
maximal activation (Vmax) of WT channels resulted
in smaller current amplitudes in the mutant (Figure
2(a)). This indicated reduced A749GS current com-
pared to WT, which was compensated by a higher
driving force at peak current amplitudes due to its
more negative activation voltage range. Since analy-
sis of the QON in the long splice variants revealed
reduced surface expression of A749GL [10], this sug-
gests that the smaller current at WT Vmax observed
with A749GS might also be due to a reduction in
channel numbers at the cell surface.
Splicing-dependent differences were also found for
ASD mutation G407R. G407R reduced maximal cur-
rent amplitudes in both C-terminally long [Table 1,
10] and short Cav1.3 splice variants (Figure 3(a),
Table 1). However, in contrast to G407RL, the voltage
dependence of activation was significantly shifted in
G407RS to more negative voltages (Figure 3(b)). Like
for G407RL the inactivation time course during
5-s depolarizations was also dramatically slowed for
G407RS (Figure 3, Table 2). G407RS, in contrast to
G407RL [10] retained an initial fast inactivating com-
ponent, most likely representing residual CDI
(Figure 3(c,d)), which is more pronounced in short
Cav1.3 splice variants [25,31,32]. Despite reduced
maximal current amplitudes, the slow inactivation
resulted in larger absolute current amplitudes during
prolonged depolarization than in WTS channels
(Figure 3(c,d)). The fraction of ICa became larger
after about 200 ms and was remarkably enhanced at
the end of a 5-s pulse to Vmax for G407RS (59.9 ± 5.62
%, n = 8), compared to WTS (13.5 ± 2.09 %, n = 35)
(Figure 3(c), Table 2). The failure ofG407R currents to
inactivate prevented the measurement of steady-state
inactivation parameters. Together with the more
negative activation voltage range of G407RS, this pre-
dicts persistent inward current at even more negative
(subthreshold) potentials than for G407RL (Figure 3).
APA mutations F747L and R990H – but not
M1354I – alter channel gating
We next determined if APA mutations F747L,
R990H and M1354I (Figure 1) also interfere with
Table 2. Remaining current upon 5-s depolarization for ASD
mutations A749G and G407R.
R50 [%] R500 [%] R5000 [%] n
WTS 41.1 ± 1.84 20.7 ± 2.05 13.5 ± 2.09 35
AGS 46.2 ± 3.92 11.8 ± 1.87 8.16 ± 1.84 9
GRS 73.6 ± 4.52*** 62.6 ± 5.39*** 59.9 ± 5.62*** 8
WTL 69.5 ± 3.2 22.8 ± 2.42 6.12 ± 1.13 15
AGL 60.0 ± 4.31 7.22 ± 0.76
### 3.12 ± 0.56### 6
GRL 99.2 ± 0.65
### 98.1 ± 1.33### 80.2 ± 3.52### 13
All values are presented as mean ± S.E.M. Number of independent
transfections ≥2. ICa inactivation normalized to Imax was obtained 50,
500 and 5000 ms after depolarization to Vmax. Statistical analysis was
performed using one-way ANOVA and Bonferroni post-hoc test.
Significance ***, ### p < 0.001 in comparison to WTS (*) or WTL (
#).
n, number of experiments; R, remaining current; WT, wild-type.
Reference data, which were already published previously, are indi-
cated in italics (taken from reference 10).
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proper channel function in a similar manner as
described above. F747L resides at the intracellular
end of IIS6 just 2 amino acids upstream of A749G.
When introduced into the long splice variant
F747LL also strongly shifted the voltage depen-
dence of activation (about −17 mV) to more nega-
tive potentials, while the voltage dependence of
inactivation remained unaltered (Figure 4(a,b),
Table 3). This dramatically broadened the voltage
range in which the channel is active and increases
the window current. Moreover, F747LL currents
inactivated more slowly and showed
a significantly higher fraction of non-inactivating
ICa even after prolonged depolarizations
(Figure 4(c); Table 4 for statistics). F747LL also
significantly slowed the time course of activation
(time to peak at Vmax [ms]: WTL: 6.66 ± 0.44,
n = 35; F747LL: 30.1 ± 1.76, n = 21, p < 0.0001,
unpaired Student’s t-test; traces in Figure 4(a),
inset). Like for A749GS, current amplitudes were
smaller at positive voltages suggesting overall
reduced current through the mutated channel.
Unfortunately, quantification of the surface
expression of functional F747LL was not possible
because the mutation eliminated measurable QON
gating charge movement. As evident from the
current traces in Figure 4(a) (inset, arrows), in 27
out of 30 recordings the QON voltage sensor move-
ment, which is present in WTL in all cells, was not
detectable. We have obtained a similar decrease in
QON relative to ionic current previously for APA
mutations I750M, V259D and P1336R [11] and
ASD mutation A749G [10] when introduced into
the long splice variant. Taken together, F747LL
exhibits the typical gating changes observed for
previously studied mutations clearly identifying
Figure 3. Biophysical properties of Cav1.3 mutant G407RS. (a) Current-voltage relationships (ICa, mean ± S.E.M.) from WTS and G407RS
recorded in parallel on the same days (>3-different transfections). Inset (upper): Box plots showing significantly reduced peak current
densities for G407RS (median (5/95 percentile) [pA/pF]: WTS: −6.68 (−17.1/-3.09), n = 17; G407RS: −2.82 (−4.36/-1.46), n = 13; ***
p < 0.0001, Mann Whitney test). Inset (lower): Representative ICa traces of WTS and G407RS upon depolarization to Vmax. (b) Voltage
dependence of WT (black circles) and G407RS (red circles) activation. Lines without symbols depict the corresponding voltage-
dependence of activation for full length WTL (black) and G407RL (red) recorded under identical conditions (taken from reference 10).
Statistics for gating parameters are given in Table 1. (c) Normalized inactivation time course of ICa after 5-s depolarization to Vmax
(mean ± S.E.M.). The fast inactivating component is reduced in G407RS (n = 8) as compared to WT (n = 35) leading to slower
inactivation of the mutant (for statistics see Table 2). (d) Although G407RS maximal current density is significantly smaller than WTS,
absolute G407RS current is larger than WTS after about 200 ms.
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Figure 4. Biophysical properties of Cav1.3 mutant F747LL. (a) Current-voltage relationships (ICa, mean ± S.E.M.) of WTL and F747LL
recorded in parallel on the same days (>3-different transfections). Inset (upper): Box plots of peak current densities (median, 5/
95 percentile, [pA/pF]): WTL: −12.7 (−66.1/-5.96), n = 47; F747LL: −13.3 (−40.3/-3.97), n = 27). Black circles represent extreme values.
Peak values were not statistically different (Mann Whitney test, p = 0.97). Inset (lower): Representative ICa traces of WTL and F747LL
upon depolarization to Vmax. Note the slower activation time course and the absence of QON gating charge in F747LL (arrows). (b)
Steady-state activation (circles, solid lines) and inactivation (squares, dashed lines) of WTL (black symbols) and F747LL (gray symbols).
Gating parameters and statistics are given in Table 3. (c) Normalized inactivation time course of ICa after 5-s depolarization to Vmax
(mean ± S.E.M.) illustrating pronounced slowing of inactivation by F747L.(n = 10) as compared to WTL (n = 28). For statistics, see
Table 4.
Table 3. Activation and inactivation parameters for APA mutations F747L and M1354I.
activation inactivation
Vrev [mV] Slope [mV] V0.5 [mV] n V0.5 [mV] Slope [mV] Remaining current [%] n
WTL 70.4 ± 0.67 9.06 ± 0.12 1.37 ± 0.60 63 −27.0 ± 0.69 5.54 ± 0.18 14.4 ± 2.02 28
FLL 53.8 ± 0.91*** 6.62 ± 0.22*** −15.6 ± 0.71*** 30 −29.3 ± 0.98* 4.45 ± 0.32** 32.2 ± 2.50*** 19
MIL 69.5 ± 0.69 9.01 ± 0.13 2.48 ± 0.79 40 −25.0 ± 0.82 5.57 ± 0.22 19.6 ± 2.26 25
WTS 64.9 ± 1.04 7.71 ± 0.11 −9.49 ± 0.42 66 −31.7 ± 0.88 4.31 ± 0.12 11.5 ± 2.18 25
MIS 62.5 ± 1.36 7.36 ± 0.18 −9.01 ± 0.64 19 −30.8 ± 0.86 3.92 ± 0.18 13.8 ± 2.49 13
All values are presented as mean ± S.E.M. Number of independent transfections >3. Parameters were obtained after fitting normalized (I/Imax)
I-V relationships or normalized (I/Imax) steady-state inactivation curves, as described in Methods. Statistical analysis was performed by one-way
ANOVA and Bonferroni post-hoc test (long splice variants) or unpaired Student’s t-test (short splice variants). Significance * p < 0.05, ** p < 0.01,
*** p < 0.001 in comparison to WTL. n, number of experiments; V0.5, half maximal activation/inactivation voltage; Vrev, reversal potential; WT, wild-
type.
Table 4. Remaining current upon 5-s depolarization for APA mutations F747L and M1354I.
R50 [%] R500 [%] R5000 [%] n
WTL 71.7 ± 2.38 29.4 ± 2.11 9.83 ± 1.86 28
FLL 99.3 ± 0.83
### 63.4 ± 4.78### 32.2 ± 3.52### 10
MIL 69.9 ± 3.64 29.7 ± 3.81 16.1 ± 3.84 12
WTS 41.1 ± 1.84 20.7 ± 2.05 13.5 ± 2.09 35
MIS 44.2 ± 3.70 23.9 ± 3.99 18.4 ± 4.34 9
All values are presented as mean ± S.E.M. Number of independent transfections >3. ICa inactivation normal-
ized to Imax was obtained 50, 500 and 5000 ms after depolarization to Vmax. Statistical analysis was
performed using one-way ANOVA and Bonferroni post-hoc test (long splice variants or unpaired Student’s
t-test (short splice variants). Significance ### p < 0.001 in comparison to WTL. n, number of experiments; R,
remaining current; WT, wild-type.
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this mutation as the cause for excess aldosterone
production in APAs.
Unlike previously described APA mutations,
R990H and M1354I are not located within the
activation gate or the S4-S5 linkers [18,21] and
may therefore induce different functional changes.
R990H replaces the third (R3) of the five S4
positive charges of the domain III voltage sen-
sing S4 helix [21]. We have recently shown that,
when introduced into the long splice variant,
R990HL causes gating changes compatible with
a loss-of-function phenotype: it tended to reduce
inward current at all voltages, and slightly but
significantly shifted activation (by about 3 mV)
to more positive rather than negative voltages as
in all other mutations studied so far (Table 5).
For this mutation we have previously provided
experimental and molecular modeling evidence
for an ω-current through the voltage-sensor.
This can be explained by a water wire formed
in the voltage-sensor of the R990H mutation,
which enables cationic leak current at hyperpo-
larized resting membrane potentials and there-
fore can indirectly trigger depolarization-induced
Ca2+ entry in APAs [21]. However, it is also
possible that a gain-of-function phenotype is
absent when introduced into the long but pre-
sent in the short splice variant. We therefore
tested this possibility by analyzing R990HS
(Figure 5). Like R990HL, R990HS shifted activa-
tion voltage to more positive voltages by about 4
mV (Figure 5, Table 5). However, when intro-
duced into the short splice variant R990H also
significantly shifted steady-state inactivation by
about 6 mV to more negative voltages thus
even reducing window current by decreasing
channel availability at negative voltages. Current
density (Figure 5(a)) and the time course of
inactivation (Table 6) were not affected by the
mutation in neither of the splice variants. In the
absence of any other significant changes
observed in R990HS these findings provide addi-
tional evidence for a loss-of-function phenotype
of this mutation for Ca2+ entry through the
canonical ion pore of both long and short var-
iants of the channel. This further strengthens the
view that the pathogenic gain-of-function pheno-
type results from its ω-current.
Mutation M1354I is located in a highly con-
served region at the extracellular end of segment
IVS5 closely interacting with segment IIIS1 and
the pore loop in domain IV [33], interactions
that may be involved in coupling the voltage sen-
sing domain to the pore domain [34]. However, in
contrast to the other mutations, M1354I neither
altered the voltage dependence of activation or
inactivation (Figure 6(a–c), Table 3) nor the time
course of inactivation during 5-s depolarizing
pulses to Vmax (Figure 6(f,g), Table 4). In addition
M1354IL did not change the Itail/QON ratio as an
indirect measure of open probability ((Itail/QON
[ms−1]: WTL: 15.8 ± 1.77, n = 16; M1354IL:
18.3 ± 1.70, n = 17, p = 0.3067, unpaired
Student’s t-test). Current densities were reduced
at all voltages in both long (Figure 6(a)) and short
Cav1.3 variants (Figure 6(b)), which could be
explained by less surface expression of the mutant
as evident from a significantly lower QON as com-
pared to WTL ((QON [pA*ms]: WTL: 144.7 ± 29.8,
n = 16; M1354IL: 60.0 ± 7.38, n = 17, p = 0.008,
unpaired student’s t-test).
A more detailed characterization of its gating
properties further revealed no changes in recovery
from inactivation determined by 10-ms test pulses to
Vmax at different time-points after a 5-s conditioning
pulse to Vmax (Figure 6(d)). Accumulation of
Table 5. Activation and inactivation parameters for APA mutation R990H.
activation inactivation
Vrev [mV] Slope [mV] V0.5 [mV] n V0.5 [mV] Slope [mV] Remaining current [%] n
WTS 64.9 ± 1.04 7.71 ± 0.11 −9.49 ± 0.42 66 −31.7 ± 0.88 4.31 ± 0.12 11.5 ± 2.18 25
RHS 60.0 ± 1.73 7.55 ± 0.19 −5.37 ± 0.63*** 11 −37.3 ± 0.57** 5.26 ± 0.53* 3.92 ± 2.42 8
WTL 66.2 ± 1.10 9.02 ± 0.23 −0.65 ± 1.27 29 −30.8 ± 1.14 5.38 ± 0.30 11.3 ± 2.35 16
RHL 69.7 ± 1.57 8.57 ± 0.14 2.61 ± 0.69
# 33 −32.5 ± 1.12 6.76 ± 0.39# 11.3 ± 2.05 18
All values are presented as mean ± S.E.M. Number of independent transfections >3. Parameters were obtained after fitting normalized (I/Imax)
I-V relationships or normalized (I/Imax) steady-state inactivation curves, as described in Methods. Statistical analysis was performed by unpaired
Student’s t-test. Significance *, # p < 0.05, **, ## p < 0.01, ***, ### p < 0.001 in comparison to WTS (*) or WTL (
#). n, number of experiments; V0.5, half
maximal activation/inactivation voltage; Vrev, reversal potential; WT, wild-type. Reference data, which were already published previously, are
indicated in italics (taken from reference 21).
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M1354IL in inactivated states induced by repetitive
3-Hz stimulation (30 100-ms steps to Vmax) did also
not differ from WT (Figure 6(e)).
Taken together, our data clearly show that APA
mutations F747L and R990H can lead to functional
changes permitting enhanced voltage-dependent Ca2+
entry into APAs through differentmolecularmechan-
isms. They can therefore explain the excessive aldos-
terone production in these tumors. In contrast,
a pathogenic role ofmutationM1354I was not evident
from our study.
Discussion
We and others, have previously discovered an
important pathophysiological role of gating
changes of de novo CACNA1D mutations, which
are capable of enhancing Ca2+ influx through Cav
1.3 channels. Such mutations occur as somatic
mutations in APAs (resulting in treatment-
resistant hypertension) and, if present germline,
cause a neurodevelopmental disorder with a wide
symptomatic spectrum. From a diagnostic point of
view, it is important to distinguish pathogenic
mutations causing the disease from other rare
polymorphisms with low disease risk or no disease
relevance at all.
Here we further expand our collection of func-
tionally verified pathogenic mutations by demon-
strating that APA mutation F747L exhibits very
similar gating changes as previously observed for
other mutations [9–12,15, Table 7], all character-
ized by a strong negative shift of activation and
inactivation voltage. This facilitates channel open-
ing by weaker depolarizations from negative
Figure 5. Biophysical properties of Cav1.3 mutant R990HS. (a) Current-voltage relationships (ICa, mean ± S.E.M.) from WTS and R990HS
recorded in parallel on the same days (>3-different transfections). Inset (upper): Box plots of peak current densities (median (5/95 percentile,
[pA/pF]): WTS: −7.96 (−39.2/-3.03), n = 10; R990HS:−10.8 (−29.8/-4.65), n = 11; p = 0.549, MannWhitney test). Inset (lower): Representative ICa
traces of WTS and R990HS upon depolarization to Vmax. (b) Steady-state activation (circles, solid lines) and inactivation (squares, dashed lines)
of WTS and R990HS. For statistics and n-numbers see Table 5. Lines without symbols depict the corresponding voltage-dependence of
activation and inactivation for full length WTL and R990HL for comparison [21] (c) Normalized inactivation time course of ICa after
5-s depolarization to Vmax (mean ± S.E.M.) for WTS (n = 35) and R990HS (n = 9). For statistics, see Table 6.
Table 6. Remaining current upon 5-s depolarization for APA
mutation R990H.
R50 [%] R500 [%] R5000 [%] n
WTS 41.1 ± 1.84 20.7 ± 2.05 13.5 ± 2.09 35
RHS 46.6 ± 3.45 19.5 ± 3.73 15.1 ± 3.54 9
WTL 69.7 ± 3.94 24.8 ± 3.50 11.1 ± 2.94 10
RHL 67.1 ± 3.59 21.6 ± 3.75 13.6 ± 3.62 12
All values are presented as mean ± S.E.M. Number of independent
transfections >3. ICa inactivation normalized to Imax was obtained 50,
500 and 5000 ms after depolarization to Vmax. Statistical analysis was
performed using unpaired Student’s t-test in comparison to WTS or
WTL. n, number of experiments; R, remaining current; WT, wild-type.
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Figure 6. Biophysical properties of Cav1.3 mutant M1354I. (a) Current-voltage relationships (ICa, mean ± S.E.M.) of WTL andM1354IL recorded
in parallel on the same days (>3-different transfections). Inset (upper): Box plots of peak current densities (median, 5/95 percentile, [pA/pF]):
WTL: −10.9 (−72.3/-5.86) n = 38; M1354IL: −8.33 (−25.3/-4.44), n = 40) were significantly smaller for the mutant (Mann Whitney test,
p = 0.029). Inset (lower): Representative ICa traces of WTL and M1354IL upon depolarization to Vmax. (b) Current-voltage relationships (ICa,
mean ± S.E.M.) of WTS and M1354IS recorded in parallel on the same days (>3-different transfections). Inset (upper): peak current densities
(median, 5/95 percentile, [pA/pF]): WTS: −7.50 (−28.5/-3.63), n = 30; M1354IS: −5.89 (−12.6/-3.00), n = 19) were significantly smaller for the
mutant (Mann Whitney test, p = 0.037). Inset (lower): Representative ICa traces of WTS and M1354IS upon depolarization to Vmax. (c) M1354I
steady-state activation (circles, solid lines) and inactivation (squares, dashed lines) of WTL (filled black symbols), M1354IL (filled blue symbols),
WTS (open black symbols), and M1354IS (open blue symbols). No significant changes were observed in mutant channels. Gating parameters
and statistics are given in Table 3. (d) Recovery from ICa inactivation (mean ± S.E.M.) of WTL and M1345IL. First 300 ms are magnified in the
inset. Curves were fitted using a mono-exponential function; there was no difference in the time constants (τ as mean ± S.E.M [ms]: WTL:
166.1 ± 20.6, n = 5; M1354IL: 154.5 ± 42.5, n = 5; unpaired Student’s t-test). E: Fraction of Imax remaining after repetitive depolarizations to
Vmax at 3 Hz (mean ± S.E.M.) of WTL (n = 10) versus M1345IL (n = 5). (f) Normalized inactivation time course of ICa after 5-s depolarization to
Vmax (mean ± S.E.M.) of WTL (n = 35) and M1354IS (n = 9). For statistics, see Table 4.
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resting membrane potentials and enables window
current at subthreshold voltages. Although the
time course of ICa inactivation during long depo-
larizations is variable, several of the mutants
(G403D, G403R, G407R) are characterized by
a very strong loss of slow inactivation giving rise
to a large fraction of non-inactivated current even
after 5-s depolarizations to Vmax. Interestingly, in
contrast to G403D and G403R [15], G407R caused
no negative shift in activation voltage when intro-
duced into the C-terminally long Cav1.3 α1 splice
variant [10]. However, our present data show that
such a negative shift (of about −6 mV) is observed
when introduced into the short splice variant.
Thus, more negative activation voltage range
seems to be the common hallmark of the majority
of pathogenic gating-modifying CACNA1D muta-
tions analyzed so far.
Splice-variant dependent gating changes are of
particular interest for germline mutations, since
the relative expression of Cav1.3 splice variants
differs across different tissues and within brain
regions and might therefore result in tissue-
specific phenotypes. For example, a particularly
high relative expression of short splice variants is
observed in dopamine neurons in the Substantia
nigra [35]. Splice-variant dependent mutational
effects have also been reported for other voltage-
gated Ca2+ channels. A single missense mutation
in exon 24 (III-IV cytoplasmic linker) in the
α1-subunit of Cav3.2 T-type channels
(CACNA1H), which confers part of the risk for
epilepsy in GAERS rats, speeds recovery from
inactivation and thereby increases Ca2+ currents
during repetitive depolarizations [36]. This pheno-
type was only observed in channels also containing
a short exon 25. The inclusion of this exon slowed
recovery from inactivation as compared to chan-
nels devoid of exon 25, and the mutation offset
this effect. Likewise, alternative splicing in the
C-terminal tail of Cav2.1 α1-subunits of P/Q-type
channels (CACNA1A) affected the functional
changes of several gain-of-function missense
mutations causing Familial Hemiplegic Migraine
Type 1 [8], including S218L. It is possible that this
mechanism also contributes to the differential
effects of this mutation on neurotransmission at
cortical pyramidal (gain-of-function of excitatory
neurotransmission) and multipolar interneurons
(unaltered inhibitory neurotransmission) in
S218L knockin mice [37].
In addition, our data further strengthen our
previous finding that ω-currents through the vol-
tage sensor could represent an alternative molecu-
lar mechanism how CACNA1D mutations could
drive depolarization and subsequent activation of
voltage-gated Ca2+-entry [21]. APA mutation
R990H affects the basic charge R3 in the voltage-
sensor of domain III of the Cav1.3 α1-subunit and
allows permeation of cation flux at resting
Table 7. Classification of CACNA1D missense mutations by characteristic functional changes.
Type Mutation Disease phenotype
Characteristic functional changes
(channel complexes of mutant α1-subunits with α2δ1 and β3) References
1 G403D APAs; hyperaldosteronism or
hyperinsulinism with seizures and
developmental delay
● Inactivation almost abolished (voltage-dependence of inacti-
vation not measurable)
● Voltage-dependence of activation shifted to hyperpolarized vol-
tages or unchanged
[15]
G403R APAs [15]
G407R ASD (and ID) [10]
2 V259D APAs ● Voltage-dependence of activation strongly shifted to hyperpo-
larized voltages
● Inactivation not abolished* with voltage-dependence of inactiva-
tion strongly shifted to hyperpolarized voltages or unchanged
* may be faster, slower, more or less complete after 5 s depolar-
izations to Vmax
[11]
V401L ASD, ID and seizures [9]
F747L APAs [11]
A749G ASD (and ID) [9,16]
I750M APAs; hyperaldosteronism with seizures
and developmental delay
[11,15]
V1153G APAs [12]
3 Q558H ID, seizures, hearing impairment ● Slower and less complete inactivation during
3–5s depolarizations to Vmax and
● no changes in voltage-dependence of gating
[14]
P1336R APAs [11]
4 R990H APAs ● Mutation-induced (depolarizing) ω-current [11,21]
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membrane potentials compatible with the forma-
tion of a water wire as predicted by molecular
dynamics simulations [21]. However, to support
the hypothesis of a pathogenic role of this
mechanism the absence of typical gating changes
as described for other mutations needs to be
demonstrated. While we have shown this earlier
for the long splice variant of Cav1.3 (R990HL), we
here complement our findings by also demonstrat-
ing that gain-of function gating changes are also
absent in R990HS.
We were unable to demonstrate any functional
consequences for APA mutation M1354I despite an
extensive analysis of its gating properties and charac-
terization of the mutation in both splice variants. The
only significant change was a small reduction in max-
imal current amplitude compared to WT in both
splice variants. However, based on findings in Cav
1.3 knockout mice and humans with CACNA1D
mutations [19,20], a loss-of-function phenotype by
a heterozygous de novo mutation is unlikely to be
pathogenic. At present, we cannot rule out the possi-
bility that a special combination of accessory β- and
α2δ-subunits, other splice variants or a yet unknown
molecular mechanism not active in our expression
system can unmask functional changes in M1354I
channels. An alternative possibility is that this rare
variant is not responsible for excess aldosterone pro-
duction in APAs. This is supported by the fact that
high-confidence somatic nonsynonymous
CACNA1D variants that passed stringent in silico
filtering have recently been described in APCCs [22]
that are also unlikely to be pathogenic. This includes
two premature stop codons. One of these (R510X)
must result in a truncated non-functional channel.
Another APA mutation, V728I, reported previously
only once in an APA of a Chinese patient [18,38] is
frequently present germline in healthy individuals [39
heterozygous alleles in EXAC database]. This also
questions if it alone can account for excessive aldos-
terone production. Since this mutation is located on
the extracellular end of helix IIS6 it is outside the
regions highly vulnerable to mutational gating defects
[S4, S4-S5-linker, cytoplasmic end of S6; 18].
Functional characterization of this mutation must
therefore address its potential pathogenic role.
Our work also has important diagnostic conse-
quences. First, by extending the list of APA muta-
tions for which we can demonstrate functional
changes compatible with a pathogenic phenotype,
we facilitate future genetic diagnosis in patients
with neurodevelopmental syndromes of unknown
cause. If any of these APA mutations were identi-
fied germline in such patients, this would provide
robust evidence for a causal role in their disease,
even if endocrine symptoms were absent. Although
APA mutations can drive excess aldosterone pro-
duction in these benign tumors, hyperaldosteron-
ism has so far only been reported for two mutations
in three (two with G403D, one with I750M) of the
patients with germline missense mutations. No
endocrine abnormalities were reported in the clini-
cally well-studied patient carrying the V401L APA
mutation [9]. At present the overall number of
patients with germline mutations is too small for
a reliable genotype-phenotype correlation.
Second, we show that the typical (“diagnostic”)
gating changes, despite significant differences, are
found in long and short Cav1.3 splice variants.
Therefore, for further routine diagnostics, analysis in
one of the splice variants is sufficient if the diagnostic
hallmarks can be demonstrated therein.
Characterization of a larger set of mutations now
allows us to propose four different characteristic
types based on functional criteria (Table 7): Type 1
are the inactivation-deficient mutations, in which
most of the Cav1.3 current fails to inactivate in Cav
1.3L. These comprise G403D, G403R, G407R. They
could also be classified as “Timothy Syndrome- like”
mutations because they are very similar to the Cav1.2
α1-subunit (CACNA1C) mutations diagnostic for
Timothy Syndrome [40,41]. Type 2 mutations still
inactivate to variable extents but are characterized by
pronounced negative shifts of activation voltage with
or without a strong negative shift also of inactivation
voltage (A749G, I750M,V401L, V1153G, V259D and,
as reported here, F747L). Type 3 is characterized only
by slower and less complete inactivation after 3–5 s at
Vmax, which should favor persistent current in cells
during prolonged depolarizations. Type 4 are muta-
tions in the voltage sensor (e.g. S4 helix positive
charges), which enable depolarizing ω-currents as
described in several other voltage-gated Ca2+-
channels [39,42–44]. Mutations without a functional
phenotype in vitro as shown here for M1354I should
be considered rare non-pathogenic variants until
further functional or clinical proof for their patho-
genicity can be obtained.
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